These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21389970)
1. Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor. Gilbert RE; Huang Q; Thai K; Advani SL; Lee K; Yuen DA; Connelly KA; Advani A Kidney Int; 2011 Jun; 79(12):1312-21. PubMed ID: 21389970 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy. Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes. Wassef L; Kelly DJ; Gilbert RE Kidney Int; 2004 Nov; 66(5):1805-14. PubMed ID: 15496151 [TBL] [Abstract][Full Text] [Related]
5. High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. Saad S; Stevens VA; Wassef L; Poronnik P; Kelly DJ; Gilbert RE; Pollock CA Kidney Int; 2005 Sep; 68(3):985-97. PubMed ID: 16105029 [TBL] [Abstract][Full Text] [Related]
6. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism. Advani A; Huang Q; Thai K; Advani SL; White KE; Kelly DJ; Yuen DA; Connelly KA; Marsden PA; Gilbert RE Am J Pathol; 2011 May; 178(5):2205-14. PubMed ID: 21514434 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379 [TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961 [TBL] [Abstract][Full Text] [Related]
9. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats. Jiang ZZ; Liu YM; Niu X; Yin JY; Hu B; Guo SC; Fan Y; Wang Y; Wang NS Stem Cell Res Ther; 2016 Feb; 7():24. PubMed ID: 26852014 [TBL] [Abstract][Full Text] [Related]
10. Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury. Park JH; Park J; Hwang SH; Han H; Ha H Transplant Proc; 2012 May; 44(4):1123-6. PubMed ID: 22564642 [TBL] [Abstract][Full Text] [Related]
11. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Zimpelmann J; Kumar D; Levine DZ; Wehbi G; Imig JD; Navar LG; Burns KD Kidney Int; 2000 Dec; 58(6):2320-30. PubMed ID: 11115066 [TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Wang X; Liu J; Zhen J; Zhang C; Wan Q; Liu G; Wei X; Zhang Y; Wang Z; Han H; Xu H; Bao C; Song Z; Zhang X; Li N; Yi F Kidney Int; 2014 Oct; 86(4):712-25. PubMed ID: 24717296 [TBL] [Abstract][Full Text] [Related]
13. Increased epidermal growth factor in experimental diabetes related kidney growth in rats. Gilbert RE; Cox A; McNally PG; Wu LL; Dziadek M; Cooper ME; Jerums G Diabetologia; 1997 Jul; 40(7):778-85. PubMed ID: 9243098 [TBL] [Abstract][Full Text] [Related]
14. Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure. Komers R; Oyama TT; Beard DR; Tikellis C; Xu B; Lotspeich DF; Anderson S Kidney Int; 2011 Feb; 79(4):432-42. PubMed ID: 20962741 [TBL] [Abstract][Full Text] [Related]
15. EGFR-PLCgamma1 signaling mediates high glucose-induced PKCbeta1-Akt activation and collagen I upregulation in mesangial cells. Wu D; Peng F; Zhang B; Ingram AJ; Kelly DJ; Gilbert RE; Gao B; Kumar S; Krepinsky JC Am J Physiol Renal Physiol; 2009 Sep; 297(3):F822-34. PubMed ID: 19605547 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254 [TBL] [Abstract][Full Text] [Related]
17. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats]. Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713 [TBL] [Abstract][Full Text] [Related]
18. Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Wang S; Chen Q; Simon TC; Strebeck F; Chaudhary L; Morrissey J; Liapis H; Klahr S; Hruska KA Kidney Int; 2003 Jun; 63(6):2037-49. PubMed ID: 12753291 [TBL] [Abstract][Full Text] [Related]
19. Zinc supplementation partially prevents renal pathological changes in diabetic rats. Tang Y; Yang Q; Lu J; Zhang X; Suen D; Tan Y; Jin L; Xiao J; Xie R; Rane M; Li X; Cai L J Nutr Biochem; 2010 Mar; 21(3):237-46. PubMed ID: 19369054 [TBL] [Abstract][Full Text] [Related]
20. [Expression of VEGF in kidney of diabetic rats]. Chen ZJ; Yang YB; Huang SM Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]